Aptevo Therapeutics Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Aptevo Therapeutics Inc. (APVO) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $164.87 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2025-02-14
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-03-31 was $5.93, a 14725.00% increase year-over-year.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2022-09-30 was $0.03, a 50.00% increase year-over-year.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2022-06-30 was $0.03, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2022-03-31 was $0.04.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was $164.87, a 82335.00% increase from fiscal 2022.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was $0.20, a 0.00% change from fiscal 2021.
- Aptevo Therapeutics Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2021 was $0.20.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $164.87 10-K · filed 2025-02-14 | $0.10 10-K · filed 2024-03-05 | ||||||
| 2023-09-30 | $4.62 10-Q · filed 2024-11-07 | $0.11 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | $5.79 10-Q · filed 2024-08-08 | $0.13 10-Q · filed 2023-08-10 | ||||||
| 2023-03-31 | $5.93 10-Q · filed 2024-05-08 | $0.13 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | $0.20 10-K · filed 2024-03-05 | |||||||
| 2022-09-30 | $0.03 10-Q · filed 2023-11-14 | $0.10 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | $0.03 10-Q · filed 2023-08-10 | $0.07 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | $0.04 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | $0.20 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | $0.02 10-Q · filed 2022-11-10 | $0.14 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $0.03 10-Q · filed 2022-08-11 | $0.12 10-Q · filed 2022-08-11 | ||||||
| 2017-09-30 | $1.63 10-Q · filed 2018-11-14 | $1.87 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | $0.14 10-Q · filed 2018-08-09 | $0.22 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $0.08 10-Q · filed 2018-05-10 | |||||||
| 2016-09-30 | $0.08 10-Q · filed 2017-11-13 | $0.31 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |